|
Real-time Estimate
Cboe Europe
09:47:43 2026-09-21 EDT
|
5-day change | 1st Jan Change | ||
| 1.533 EUR | -0.45% |
|
-3.29% | -59.42% |
| 08-14 | Optomed Oyj Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-14 | Optomed Oyj Provides Earnings Guidance for the Year 2026 | CI |
| Market Cap | 33.07M 37.92M 31.23M 28.36M 53.13M 3.64B 53.35M 374M 144M 1.85B 142M 139M 5.95B | P/E 2026 * |
-9.94x | P/E 2027 * | -14x |
|---|---|---|---|---|---|
| Enterprise Value | 30.07M 34.48M 28.39M 25.78M 48.31M 3.31B 48.51M 340M 131M 1.68B 130M 127M 5.41B | EV / Sales 2026 * |
1.71x | EV / Sales 2027 * | 1.56x |
| Free-Float |
94.26% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Helsinki
| OPTOMED | Delayed | |
CBOE
| Real-time | ||
|
CBOE
| Real-time | ||
|
Deutsche Boerse AG
| 36U0 | Delayed |
| 1 day | -0.45% | ||
| 1 week | -3.29% | ||
| Current month | -7.72% | ||
| 1 month | -9.79% | ||
| 3 months | -7.83% | ||
| 6 months | -37.42% | ||
| Current year | -59.42% |
| 1 week | 1.5 |  | 1.6 |
| 1 month | 1.5 | | 1.72 |
| Current year | 1.33 | | 4.1 |
| 1 year | 1.33 | | 4.33 |
| 3 years | 1.33 | | 7.74 |
| 5 years | 1.33 | | 12.9 |
| 10 years | 1.33 | | 19.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2023-09-30 | |
| Director of Finance/CFO | 42 | 2022-08-04 | |
Petri Huhtinen
CTO | Chief Tech/Sci/R&D Officer | - | 2019-10-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 68 | 2005-12-31 | |
| Director/Board Member | 74 | 2018-12-31 | |
| Director/Board Member | 70 | 2018-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/26/25 | Free | Chief Financial Officer | 40,000 | 0.2031% | ||
| 9/26/25 | Free | Executive/Senior Manager | 30,000 | 0.1523% | ||
| 9/26/25 | Free | Executive/Senior Manager | 20,000 | 0.1016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.45% | -3.29% | -58.14% | -46.13% | 37.92M | |
| +0.45% | +6.47% | +37.55% | +30.25% | 241B | |
| +0.92% | +4.63% | +11.65% | -14.81% | 149B | |
| +0.17% | +4.12% | -11.48% | +38.40% | 139B | |
| -0.44% | -4.73% | -55.77% | -20.47% | 62.81B | |
| -0.01% | +3.24% | +19.72% | +25.81% | 50.87B | |
| -0.36% | -3.69% | -19.95% | -17.91% | 48.21B | |
| +1.51% | +7.92% | +25.40% | +44.37% | 44.11B | |
| +0.59% | +3.45% | +40.22% | +57.75% | 41.42B | |
| +2.87% | +17.07% | +140.18% | +82.82% | 36.18B | |
| Average | +0.54% | +4.74% | +12.94% | +18.01% | 81.24B | |
| Weighted average by Cap. | +0.53% | +5.73% | +16.72% | +20.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 17.63M 20.22M 16.65M 15.12M 28.33M 1.94B 28.45M 199M 76.96M 987M 75.96M 74.28M 3.17B | 20.6M 23.62M 19.45M 17.66M 33.09M 2.27B 33.23M 233M 89.91M 1.15B 88.74M 86.77M 3.71B |
| Net income | -2.95M -3.38M -2.79M -2.53M -4.74M -325M -4.76M -33.37M -12.88M -165M -12.71M -12.43M -531M | -2.3M -2.64M -2.17M -1.97M -3.69M -253M -3.71M -26.01M -10.04M -129M -9.91M -9.69M -414M |
| Net Debt | -3M -3.44M -2.83M -2.57M -4.82M -330M -4.84M -33.93M -13.09M -168M -12.92M -12.64M -540M | -1M -1.15M -944K -857K -1.61M -110M -1.61M -11.31M -4.36M -55.95M -4.31M -4.21M -180M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-21 | €1.530 | -0.65% | 53,797 |
| 26-09-18 | €1.540 | -1.28% | 69,289 |
| 26-09-17 | €1.560 | -0.26% | 51,198 |
| 26-09-16 | €1.564 | -1.01% | 8,462 |
| 26-09-15 | €1.580 | -0.13% | 31,843 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OPTOMED Stock
Select your edition
All financial news and data tailored to specific country editions
